Alexander Stratford

Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐<i>d</i>‐lysergic acid diethylamide (1P‐LSD)

Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal et al. · Drug Testing and Analysis · 2015 · 79 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Return of the lysergamides. Part V: Analytical and behavioural characterization of 1‐butanoyl‐<i>d</i>‐lysergic acid diethylamide (1B‐LSD)

Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal et al. · Drug Testing and Analysis · 2019 · 72 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Return of the lysergamides. Part II: Analytical and behavioural characterization of <i>N</i>⁶‐allyl‐6‐norlysergic acid diethylamide (AL‐LAD) and (2’<i>S</i>,4’<i>S</i>)‐lysergic acid 2,4‐dimethylazetidide (LSZ)

Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal et al. · Drug Testing and Analysis · 2016 · 62 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM‐775)

Simon D. Brandt, Pierce V. Kavanagh, Brendan Twamley et al. · Drug Testing and Analysis · 2017 · 56 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures

Lea Wagmann, Lilian H.J. Richter, Tobias Kehl et al. · Analytical and Bioanalytical Chemistry · 2019 · 53 citations · Full text

Pharmacy, Pharmacology, Toxicology +16